05/20/2019
https://congress.gov...
"I look forward to continued discussions with my colleagues in the House on other member priorities that could strengthen this important legislation."
"I am committed to ensuring patient safety while minimizing regulatory burden."
"Today's hearing is a great opportunity for us to learn more about four bipartisan medical device bills that could potentially be included in this effort."
"We meet today to once again discuss the FDA's vitally important user fee programs, as you all know."